Collplant

4 stories about Collplant
קולפלנט דיו ביולוגי

Global Licensing and Commercialization Deal Catapults Collplant on Nasdaq

22.10.18|Lilach Baumer
The tissue regeneration company announced on Monday a deal with biotech company United Therapeutics and is currently up over 60% in pre-market trading
קולפלנט דיו ביולוגי

Tissue Regeneration Company Collplant Wants to Delist From Tel Aviv Exchange

16.04.18|Lilach Baumer
The Israel-based biotech company is trading on Nasdaq since January following a $5 million investment agreement
קולפלנט דיו ביולוגי

Collplant Secures $7.4 million in Private Placement

13.11.17|Lilach Baumer
Over the past three months, the TASE-listed regenerative medicine company submitted several filings regarding investments made by private investors
קולפלנט דיו ביולוגי

Collplant Takes a Step Towards 3D Organ Printing

17.10.17|Lilach Baumer
The Israel-based company develops collagen-based biological ink for 3D organ printing